Based on this YouTube video's total view count of 57.7K views and industry-standard rates, the estimated total earning is $40 - $116 through ad revenue. Historical data is not yet available to calculate daily, weekly, or monthly averages.

Explore The Ozempic debate: New study reveals the good, the bad and the medically ugly with 57,787 views, 208 likes, and 65 comments. Experience the impact of this video content that has captured audience attention.

Ozempic, Wegovy, Zepbound and other drugs often used for weight loss can help lower the risk of a wide range of health conditions, according to a new study. But the large observational study, published Monday in Nature Medicine, also reveals the drugs come with risks, such as pancreatitis and stomach paralysis. The study maps the risks and benefits of drugs like Ozempic across 175 potential health outcomes. Global’s Kyle Benning breaks down the findings. For more info, please go to https://globalnews.ca/news/10969594/ozempic-weight-loss-study-shows-benefits-risks/ Subscribe to Global News Channel HERE: http://bit.ly/20fcXDc Like Global News on Facebook HERE: http://bit.ly/255GMJQ Follow Global News on X HERE: http://bit.ly/1Toz8mt Follow Global News on Instagram HERE: https://bit.ly/2QZaZIB #GlobalNews #ozempic #semiglutide #health

With SocialCounts.org’s view counter, track your YouTube video’s live view count and YouTube likes count in real time with fast, reliable updates.

Watch every YouTube video live view count rise with our real-time YouTube views tracker—built for accuracy and minimal delay.

Follow YouTube real time views as they happen, using our dedicated view counter for YouTube videos.

Get up-to-date live view count on YouTube and see real-time growth with SocialCounts.org’s smart tracking tools.